Loading...

Home
ETF
LTRN

LTRN

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

LTRN News

Lantern Pharma (LTRN) Q1 2025 Earnings Transcript

May 21 2026NASDAQ.COM

FDA Approves Lantern's Clinical Trial Amendments

May 19 2026Newsfilter

Lantern Pharma Q1 Financial Results and Funding Update

May 15 2026seekingalpha

Lantern Pharma to Report Q1 2026 Financial Results on May 15

May 11 2026Newsfilter

Lantern Pharma Unveils New Features for withZeta.ai Platform

May 07 2026Newsfilter

Lantern Pharma Unveils New Features for withZeta.ai Platform

May 07 2026Yahoo Finance

Highlights from New to The Street Broadcast

Apr 25 2026Yahoo Finance

Lantern Pharma Launches AI Drug Discovery Platform with Subscription Tiers

Apr 14 2026Newsfilter

Lantern Pharma Unveils AI Drug Development Platform with Zeta.ai

Apr 02 2026Newsfilter

Lantern Pharma Q4 2025 Earnings Call Insights

Mar 31 2026seekingalpha

Lantern Pharma Reports Reduced Q4 Net Loss

Mar 30 2026seekingalpha

PMGC Holdings Unit Amends Clinical Trial Agreement

Mar 30 2026stocktwits

Leading Pre-Market Gainers Today — ELAB, ITRM, LTRN Among Stocks Rising Ahead of Market Open

Mar 30 2026stocktwits

Lantern Pharma Receives FDA IND Approval for STAR-001

Mar 30 2026NASDAQ.COM

Lantern Pharma CEO Panna Sharma Remains in Position, Addresses False Claims

Mar 27 2026Newsfilter

LANTERN PHARMA AFFIRMS PANNA SHARMA REMAINS PRESIDENT AND CEO; WARNS INVESTORS ABOUT INACCURATE THIRD-PARTY REPORT

Mar 27 2026moomoo